Execution-led Culture
Decisions are made by people who understand what it takes to bring a late-stage asset to approval globally. We move with discipline and focus because the moment demands it.
Careers
& Culture
Experience & compassion
united by purpose
One team driven by the conviction that the next breakthrough in MASH begins with the right people, working with the right intent.
An experienced team
Our Team
Lanifibranor was not discovered by chance. It was purposefully designed, and the scientists behind its discovery went on to found Inventiva, building a company around the conviction that pan-PPAR agonism could address the complexity of MASH. Our experienced team brings together expertise in MASH drug development, united in their commitment to advancing lanifibranor as a potential treatment for the patients who need it.
Compassion for those affected
Our Purpose
We understand that behind every data point is a person. Our commitment to patients with MASH is not a footnote to our science, it is the reason for it. Compassion shapes how we prioritize, how we move, and how we measure success.
When you join Inventiva, you are not just joining a company. You are joining a group of people who believe that the work they do every day has the potential to change the course of a progressive disease, and that belief changes how they show up.
What it means to work here
Meaningful Work
Every project is guided by the potential to contribute to better outcomes for patients living with serious disease. The link between your daily work and potential real human impact is never abstract at Inventiva.
Expert Colleagues
At Inventiva, expertise takes many forms. You will work alongside colleagues spanning science, medicine, development, regulatory, commercial, and beyond — brought together by decades of collective experience and a single shared purpose: developing a potential new therapy to MASH patients.
A Pivotal Moment
With Phase 3 topline data expected in Q4 2026, joining Inventiva now means being part of our pivotal chapter in drug development for MASH.
Open positions
Join us at a defining moment
Compliance
Senior Director, Compliance
About Inventiva Inventiva is a clinical-stage biopharmaceutical company headquartered in France, focused on the development of lanifibranor in a Phase 3 trial, NATIV3, in MASH. To learn more, please visit: https://inventivapharma.com/ We are strengthening...
View roleCommunications
Senior Director, Corporate Communications
About Inventiva Inventiva is a clinical-stage biopharmaceutical company headquartered in France, focused on the development of lanifibranor in a Phase 3 trial, NATIV3, in MASH. To learn more, please visit: https://inventivapharma.com/ The Opportunity We...
View roleDon’t see your role?
We want to hear from you.
Inventiva is built on the conviction that the right people, at the right moment, can change everything. If you share our commitment to patients with MASH and want to contribute to a pivotal chapter in drug development, reach out.
Gender Equality Index
For 2025, the Gender Equality Index of Inventiva is
94 out of 100 points
| Indicators | Number of points earned | Maximum number of points for calculable indicators |
|---|---|---|
| 1- pay gap (in %) | 40 | 40 |
| 2- individual pay increase gap (in % points or in equivalent number of employees) | 35 | 35 |
| 3- percentage of employees receiving a raise after returning from maternity leave (%) | Incalculable | Incalculable |
| 4- number of employees of the under-represented gender in the 10 highest paid | 5 | 10 |
| Total of calculable indicators | 80 | 85 |
| INDEX (out of 100 points) | 94 | 100 |
At Inventiva, we are looking for innovative people with a solid industry background to join our team.
Our world-class research organization and our commitment to the discovery of new drug candidates provide a unique opportunity for talented professionals wishing to make a difference.
If you are interested in a career with a top-notch team that progress in a creative and challenging environment, please contact us!